上海莼試生物技術(shù)有限公司
   
菜單 Close 公司首頁(yè) 公司介紹 公司動(dòng)態(tài) 產(chǎn)品展廳 證書(shū)榮譽(yù) 聯(lián)系方式 在線留言
您當(dāng)前的位置: 網(wǎng)站首頁(yè) > 產(chǎn)品展廳 >抗體 >腺苷單磷酸活化蛋白激酶γ2抗體規(guī)格
產(chǎn)品展廳
腺苷單磷酸活化蛋白激酶γ2抗體規(guī)格
  • 品牌:上海莼試
  • 產(chǎn)地:進(jìn)口、國(guó)產(chǎn)
  • 貨號(hào):CS10510
  • 發(fā)布日期: 2018-12-29
  • 更新日期: 2025-04-21
產(chǎn)品詳請(qǐng)
產(chǎn)地 進(jìn)口、國(guó)產(chǎn)
品牌 上海莼試
保存條件 Store at -20 °C
貨號(hào) CS10510
應(yīng)用范圍 WB=1:100-500 ELISA=1:500-1000 IHC-P=1:100-500 IHC-F=1:100-500 ICC=1:100-500 IF=1:50-200
CAS編號(hào)
抗體名 Anti-PRKAG2/AMPKγ2
克隆性
靶點(diǎn) 詳見(jiàn)說(shuō)明書(shū)
適應(yīng)物種 詳見(jiàn)說(shuō)明書(shū)
形態(tài) 詳見(jiàn)說(shuō)明書(shū)
宿主 詳見(jiàn)說(shuō)明書(shū)
亞型 IgG
標(biāo)識(shí)物 詳見(jiàn)說(shuō)明書(shū)
濃度 1mg/1ml%
免疫原 KLH conjugated synthetic peptide derived from human PRKAG2/AMPKγ2

全、新、優(yōu)、品、好四大特點(diǎn):

腺苷單磷酸活化蛋白激酶γ2抗體規(guī)格 全:公司提供上萬(wàn)種產(chǎn)品,涵蓋了生物試劑,elisa試劑盒,標(biāo)準(zhǔn)品,培養(yǎng)基,原裝耗材,抗體、培養(yǎng)基、ATCC細(xì)胞等,基本上各種科研所需產(chǎn)品在我司都能找到。

新:產(chǎn)品更新速度較快,基本上每周都有新產(chǎn)品出現(xiàn)。

優(yōu):產(chǎn)品質(zhì)量好,投訴比較少。

好:我公司具有優(yōu)質(zhì)的技術(shù)團(tuán)隊(duì),產(chǎn)品一旦售出,實(shí)驗(yàn)過(guò)程中遇到困難可提供在線技術(shù)咨詢。使您使用產(chǎn)品時(shí)沒(méi)有任何的后顧之憂。

腺苷單磷酸活化蛋白激酶γ2抗體規(guī)格 英文名稱  Anti-PRKAG2/AMPKγ2

中文名稱  腺苷單磷酸活化蛋白激酶γ2抗體規(guī)格 

     5'-AMP-activated protein kinase subunit gamma-2; AAKG; AMPK gamma2; AMPK gamma 2; AMPK subunit gamma 2; CMH6; H91620p.

產(chǎn)品屬性:

      1mg/1ml

規(guī)   0.2ml/200μg

抗體來(lái)源  Rabbit

克隆類型   polyclonal

交叉反應(yīng)   Human, Mouse, Rat, Chicken, Dog, Pig, Cow, Horse

產(chǎn)品類型   一抗  

研究領(lǐng)域     心 細(xì)胞生物 信號(hào)轉(zhuǎn)導(dǎo)

蛋白分子量  predicted molecular weight: 63kDa 

       Lyophilized or Liquid

  KLH conjugated synthetic peptide derived from human PRKAG2/AMPKγ2

      IgG

純化方法   affinity purified by Protein A

儲(chǔ)    Preservative: 15mM Sodium Azide, Constituents: 1% BSA, 0.01M PBS, pH 7.4

腺苷單磷酸活化蛋白激酶γ2抗體規(guī)格 產(chǎn)品應(yīng)用   WB=1:100-500 ELISA=1:500-1000 IHC-P=1:100-500 IHC-F=1:100-500 ICC=1:100-500 IF=1:50-200

(石蠟切片需做抗原修復(fù)) 

 not yet tested in other applications.

 optimal dilutions/concentrations should be determined by the end user.  

保存條件  Store at -20 °C for one year. Avoid repeated freeze/thaw cycles. The lyophilized antibody is stable at room temperature for at least one month and for greater than a year when kept at -20°C. When reconstituted in sterile pH 7.4 0.01M PBS or diluent of antibody the antibody is stable for at least two weeks at 2-4 °C. 

Important Note  This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications. 

產(chǎn)品介紹 AMPK is a heterotrimeric complex comprising a catalytic a subunit and regulatory b and g subunits. It protects cells from stresses that cause ATP depletion by switching off ATP-consuming biosynthetic pathways. AMPK is activated by high AMP and low ATP through a mechanism involving allosteric regulation, promotion of phosphorylation by an upstream protein kinase known as AMPK kinase and inhibition of dephosphorylation. Activated AMPK can phosphorylate and regulate in vivo hydroxy-methylglutaryl-CoA reductase and acetyl-CoA carboxylase, which are key regulatory enzymes of sterol synthesis and fatty acid synthesis, respectively. The human AMPKa1 and AMPKa2 genes encode 548 amino acid and 552 amino acid proteins, respectively. Human AMPKb1 encodes a 271 amino acid protein and human AMPKb2 encodes a 272 amino acid protein. The human AMPKg1 gene encodes a 331 amino acid protein. Human AMPKg2 and AMPKg3, which are 569 and 492 amino acid proteins, respectively, contain unique N-terminal domains and may participate directly in the binding of AMP within the AMPK complex.

Function : AMP/ATP-binding subunit of AMP-activated protein kinase (AMPK), an energy sensor protein kinase that plays a key role in regulating cellular energy metabolism. In response to reduction of intracellular ATP levels, AMPK activates energy-producing pathways and inhibits energy-consuming processes: inhibits protein, carbohydrate and lipid biosynthesis, as well as cell growth and proliferation. AMPK acts via direct phosphorylation of metabolic enzymes, and by longer-term effects via phosphorylation of transcription regulators. Also acts as a regulator of cellular polarity by remodeling the actin cytoskeleton; probably by indirectly activating myosin. Gamma non-catalytic subunit mediates binding to AMP, ADP and ATP, leading to activate or inhibit AMPK: AMP-binding results in allosteric activation of alpha catalytic subunit (PRKAA1 or PRKAA2) both by inducing phosphorylation and preventing dephosphorylation of catalytic subunits. ADP also stimulates phosphorylation, without stimulating already phosphorylated catalytic subunit. ATP promotes dephosphorylation of catalytic subunit, rendering the AMPK enzyme inactive.

Subunit : AMPK is a heterotrimer of an alpha catalytic subunit (PRKAA1 or PRKAA2), a beta (PRKAB1 or PRKAB2) and a gamma non-catalytic subunits (PRKAG1, PRKAG2 or PRKAG3). Interacts with FNIP1 and FNIP2.

Subcellular Location : Cytoplasmic and Nuclear

Post-translational modifications : Phosphorylated by ULK1; leading to negatively regulate AMPK activity and suggesting the existence of a regulatory feedback loop between ULK1 and AMPK. Phosphorylated upon DNA damage, probably by ATM or ATR.

DISEASE : Defects in PRKAG2 are the cause of cardiomyopathy, familial hypertrophic type 6 (CMH6) [MIM:600858]. A hereditary heart disorder characterized by ventricular hypertrophy, which is usually asymmetric and often involves the interventricular septum. The symptoms include dyspnea, syncope, collapse, palpitations, and chest pain. They can be readily provoked by exercise. The disorder has inter- and intrafamilial variability ranging from benign to malignant forms with high risk of cardiac failure and sudden cardiac death. CMH6 patients present Wolff-Parkinson-White ventricular preexcitation, enlarged myocytes without myofiber disarray, and glycogen-containing cytosolic vacuoles within cardiomyocytes.

Defects in PRKAG2 are a cause of glycogen storage disease of heart lethal congenital (GSDH) [MIM:261740]; also known as phosphorylase kinase deficiency of heart or congenital nonlysosomal cardiac glycogenosis. GSDH is a rare disease which leads to death within a few weeks to a few months after birth, through heart failure and respiratory compromise.

Similarity : Belongs to the 5'-AMP-activated protein kinase gamma subunit family.

Contains 4 CBS domains.

實(shí)驗(yàn)流程:

正在熱銷的相關(guān)產(chǎn)品:

Anti-DR3/TNF- AlphaR/TRAMP /FITC 熒光素標(biāo)記TNF-α膜受體抗體/DR3 死亡受體3抗體IgGMulti-class antibodies規(guī)格: 0.2ml

Anti-TPSB2/Tryptase Beta2/FITC 熒光素標(biāo)記兔抗人、大、小鼠肥大細(xì)胞類胰蛋白酶β2IgGMulti-class antibodies規(guī)格: 0.2ml

Rhesus antibody Rh CA12 酶12抗體 規(guī)格 0.1ml

ChRM1(music acetylcholine receptor) 毒蕈堿型乙酰膽堿受體M1抗原 0.5mg

HMX2 英文名稱: 同源盒蛋白H6亞型2抗體 0.2ml

Rhesus antibody Rh Secretin receptor 分泌素受體抗體 規(guī)格 0.2ml

Anti-TPSB2/Tryptase Beta2/FITC 熒光素標(biāo)記兔抗人、大、小鼠肥大細(xì)胞類胰蛋白酶β2IgGMulti-class antibodies規(guī)格: 0.2ml

Anti-IDE/FITC 熒光素標(biāo)記降解酶抗體IgGMulti-class antibodies規(guī)格: 0.2ml

Anti-PKN2 /FITC 熒光素標(biāo)記蛋白激酶N2抗體IgGMulti-class antibodies規(guī)格: 0.2ml

Rhesus antibody Rh ARSF 芳香基酯酶F抗體 規(guī)格 0.2ml

Donkey Anti-human IgG/PE-Cy3 PE-Cy3標(biāo)記的驢抗人IgG 0.1ml

GCAP2 英文名稱: 鳥(niǎo)苷酸環(huán)化酶激活蛋白2抗體 0.2ml

Rhesus antibody Rh Rabbit Anti-Monkey IgG/HRP 辣根過(guò)氧化物酶標(biāo)記的兔抗猴IgG 規(guī)格 0.1ml

Anti-PKN2 /FITC 熒光素標(biāo)記蛋白激酶N2抗體IgGMulti-class antibodies規(guī)格: 0.2ml

Alpha-EP(Human Alpha-Endomorphin) ELISA Kit 人α-內(nèi)*肽Multi-class antibodies規(guī)格: 48T

Anti-Phospho-Histone H2A.X (Ser139) 磷酸化組蛋白H2AX抗體Multi-class antibodies規(guī)格: 0.1ml

Rhesus antibody Rh MMP-1 基質(zhì)金屬蛋白酶-1抗體 規(guī)格 0.1ml

M2-PK (Human Pyruvate Kinase) ELISA Kit 人酸激酶M2型同工酶 96T

phospho-RAD51(Tyr315) 英文名稱: 磷酸化Rad51抗體 0.1ml

Complement C3c alpha' chain fragment 1 英文名稱: 補(bǔ)體C3cα 鏈片段1抗體 0.1ml

Anti-Phospho-Histone H2A.X (Ser139) 磷酸化組蛋白H2AX抗體Multi-class antibodies規(guī)格: 0.1ml

CM-H021人平滑肌細(xì)胞完全培養(yǎng)基100mL

FAM171B Others Human 人 FAM171B / KIAA1946 人細(xì)胞裂解液 (陽(yáng)性對(duì)照)

主動(dòng)脈平滑肌細(xì)胞Many types of cells包裝:5 × 105次方(1ml)

293001A細(xì)胞,Sars蛋白表達(dá)株 人癌細(xì)胞,MDA-MB-436細(xì)胞 雪旺細(xì)胞培養(yǎng)基SCM-prf

白牦牛皮膚細(xì)胞;Yak-2

IL35 Others Human 人 IL-35 (IL12A & IL27B) 人細(xì)胞裂解液 (陽(yáng)性對(duì)照)

CM-H020人胰島β細(xì)胞完全培養(yǎng)基100mL

STATH Others Human 人 Statherin / STATH 人細(xì)胞裂解液 (陽(yáng)性對(duì)照)

真皮淋巴上皮細(xì)胞Many types of cells包裝:5 × 105次方(1ml)

293sars181A細(xì)胞,Sars蛋白表達(dá)株 人細(xì)胞,HBL-100細(xì)胞 腎系膜細(xì)胞培養(yǎng)基MCM-prf

大額牛皮膚成纖維樣細(xì)胞;BOS-2

IL2RB Others Human 人 IL2Rβ 人細(xì)胞裂解液 (陽(yáng)性對(duì)照)

腺苷單磷酸活化蛋白激酶γ2抗體規(guī)格 MZB1 Others Human 人 MZB1 / PERP1 人細(xì)胞裂解液 (陽(yáng)性對(duì)照)

小梁網(wǎng)細(xì)胞Many types of cells包裝:5 × 105次方(1ml)

大鼠肺泡巨噬細(xì)胞;NR8383[AgC11x3A; NR8383.1]

PLC/PRF/5細(xì)胞,人亞歷山大細(xì)胞系 小鼠胚成纖維包裝細(xì)胞,PA317細(xì)胞 CL-0018A9(小鼠皮下結(jié)締組織細(xì)胞)5×106cells/瓶×2

SPC-A-1(人細(xì)胞) 5×106cells/瓶×2

HDMEC-c adult 人真皮微內(nèi)皮細(xì)胞(HDMEC)來(lái)自成年捐獻(xiàn)者 500,000cells 肝竇內(nèi)皮細(xì)胞Many types of cells包裝:5 × 105次方(1ml)

技術(shù)外包服務(wù):

腺苷單磷酸活化蛋白激酶γ2抗體規(guī)格 分子生物學(xué):質(zhì)粒抽提、PCR、Q-PCR、RT-PCR、分子生物學(xué):基因合成、引物合成、基因測(cè)序、載體構(gòu)建等

蛋白工程:原核、哺乳動(dòng)物蛋白表達(dá)系統(tǒng)等

病毒包裝:腺病毒、慢病毒等

抗體工程:磁珠分選、病理染色、WB、ELISAIP、IF、IHC、FACS、Confocal等等

細(xì)胞工程:細(xì)胞表型分析(凋亡、增殖、周期、遷移、侵襲、修復(fù)、克隆形成)、細(xì)胞培養(yǎng)、細(xì)胞膜制備、穩(wěn)定細(xì)胞株構(gòu)建、細(xì)胞RNAi技術(shù)等等。


聯(lián)系方式
手機(jī):13585831301
Q Q:
亚洲精品乱码久久久久久久久久久久,国产精品视频色尤物yw,亚洲AV日韩AV永久无码色欲,亚洲a∨精品永久无码